RecruitingNCT04577248

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Sponsor

Deutsches Herzzentrum Muenchen

Enrollment

5,000 participants

Start Date

Sep 15, 2020

Study Type

OBSERVATIONAL

Conditions

Tricuspid Valve Regurgitation Mitral Valve Regurgitation Mitral Valve Stenosis

Summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria4

Age above 18 years and consentable
Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
Written informed consent

Exclusion Criteria1

Patient's inability to fully cooperate with the protocol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEedge-to-edge valve repair

edge-to-edge valve repair

Locations(1)

Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04577248

Related Trials

STS/ACC TVT Registry Mitral Module

NCT022457631 location

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

NCT0324264285 locations